Fund: FTBDF

Franklin Templeton - Franklin Biotechnology Discovery Fund A(acc)USD - 4912
LU0109394709
03-04-2000
Equity
Equity Sectors - Health Care
Franklin Templeton Investment Funds
Franklin Advisers, Inc.
Evan McCulloch
USD
1,000
5.75%
EIC Fund Rating (2020)
Rok Rated portolio Ref. ccy Rating category Rf (p.a.) Rm (p.a.) Return (p.a.) Correlation Beta Alpha (p.a.) Rank Stars
2020 FTBDF USD EQ-SEC-HC 0.3675% 26.57% 38.12% 0.92 1.21 6.18% 3/8
2019 FTBDF USD EQ-SEC-HC 2.1319% 23.40% 35.60% 0.88 1.59 -0.45% 5/7
2018 FTBDF USD EQ-SEC-HC 1.8344% -6.34% -17.33% 0.82 1.41 -7.59% 7/8
2017 FTBDF USD EQ-SEC-HC 1.0263% 21.62% 18.79% 0.77 1.81 -19.55% 8/8
2016 FTBDF USD EQ-SEC-HC 0.3901% -9.83% -15.55% 0.77 1.69 1.31% 5/11
2015 FTBDF USD EQ-SEC-HC 0.1342% 11.89% 10.97% 0.77 1.53 -4.77% 8/11
2014 FTBDF USD EQ-SEC-HC 0.0923% 31.35% 59.54% 0.81 1.88 0.69% 5/11
44.9000
18-09-2024
0.8762%
Quick compare
1M 3M 6M 9M 1R 3R p.a. 5R p.a. 7R p.a. 10R p.a. od vnizku p.a.
Výkonnosť fondu 3.22% 9.75% 7.57% 25.98% 34.96% 1.66% 8.32% 4.38% 4.56% N/A
Priemerná výkonnosť (36 meraní) 0.31% -0.86% -0.03% 3.05% 2.42%
Volatilita od priemernej výkonnosti 9.27% 32.89% 7.60% 5.55% 4.23%
Rozloženie aktív
Long Short Net
Stock 98.56% 98.56%
Bond
Other 0.68% 0.68%
Cash 1.39% 0.63% 0.76%
Veľkosť fondu
Aktíva12,416 mil.
Počet akcíí84
Počet dlhopisov1
Nákladovosť fondu
Priebež. popl.1.81
 z toho Mng. popl.1.50
Výk. prémia
Trans. popl.0.04
Výnosovosť fondu
Dividenda
Dividendový výnos
Rozhodný dátum
Frekvencia výplaty
Akciové portfólio
Giant 2.85%
Large 25.79%
Medium 20.26%
Small 15.41%
Micro 27.26%
P/E18.74%
P/BV3.74%
Sektorové rozloženie
Basic Materials 1.08%
Healthcare 95.40%
Dlhopisové portfólio
Corporate 0.68
Derivatives 0.76
Výnos do splatnosti p.a.
Modifikovaná durácia
Kreditné rozloženie
AAA 0.00
AA 67.14
A 0.00
BBB 0.00
BB 0.00
B 0.00
Below B 0.00
Not Rated 32.86
Regionálne rozloženie
United States 84.44%
Canada 0.73%
Latin America
United Kingdom 3.30%
Eurozone 4.48%
Europe - ex Euro 4.62%
Europe - Emerging
Africa
Middle East
Japan
Australasia
Asia - Developed
Asia - Emerging
Emerging Market
Developed Country 97.58%
Not Classified
Top 10 pozícií
SpoločnosťSubsektorVáha SpoločnosťSubsektorVáha
Amgen Inc Healthcare 8.19% Regeneron Pharmaceuticals Inc Healthcare 7.14%
Vertex Pharmaceuticals Inc Healthcare 6.04% Insmed Inc Healthcare 3.76%
Ascendis Pharma A/S ADR Healthcare 3.62% Gilead Sciences Inc Healthcare 3.27%
Intra-Cellular Therapies Inc Healthcare 2.97% Biogen Inc Healthcare 2.93%
AstraZeneca PLC ADR Healthcare 2.85% Merus NV Healthcare 2.82%